Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q14568
UPID:
HS902_HUMAN
Alternative names:
Heat shock 90 kDa protein 1 alpha-like 3; Heat shock protein HSP 90-alpha A2 pseudogene
Alternative UPACC:
Q14568
Background:
Heat shock protein HSP 90-alpha A2, also known as Heat shock 90 kDa protein 1 alpha-like 3, plays a crucial role as a putative molecular chaperone. It is involved in the maturation, structural maintenance, and proper regulation of specific target proteins, ensuring their correct folding and functional activity.
Therapeutic significance:
Understanding the role of Heat shock protein HSP 90-alpha A2 could open doors to potential therapeutic strategies. Its involvement in protein folding and maintenance positions it as a key player in cellular homeostasis and health.